RATIONALE: Brain reward pathways implicated in addiction appear to be less reactive in regular drug users; behavioural manifestations may include decreased sensitivity to natural reinforcers. OBJECTIVES: This study aimed to replicate earlier findings of abstinence-associated incentive motivation deficits in smokers and to determine whether these can be reversed with nicotine in the form of lozenge. METHODS:One hundred forty-five smokers were each tested twice, once after receiving nicotine, and once after receiving placebo lozenge in counterbalanced order. Participants completed various tests of incentive motivational functioning: a measure of subjective enjoyment, the Snaith-Hamilton pleasure scale (SHAPS); a simple card sorting task, the card arranging reward responsivity objective test (CARROT) with and without financial incentive; the modified emotional Stroop test; a cue-reactivity task; and a novel reaction time task to explore effects of signals of reward, the incentive motivational enhancement of response speed task. RESULTS: Compared with performance during abstinence (placebo condition), nicotine was associated with: higher self-reported pleasure expectations on the SHAPS; enhanced responsiveness to financial reward on the CARROT in smokers who smoked 15 or more cigarettes a day; and greater interference from appetitive words on the Stroop task. CONCLUSIONS: These results are generally consistent with contemporary neurobiological theories of addiction and suggest that short-term smoking abstinence is associated with impaired reward motivation which can be reversed with nicotine.
RCT Entities:
RATIONALE: Brain reward pathways implicated in addiction appear to be less reactive in regular drug users; behavioural manifestations may include decreased sensitivity to natural reinforcers. OBJECTIVES: This study aimed to replicate earlier findings of abstinence-associated incentive motivation deficits in smokers and to determine whether these can be reversed with nicotine in the form of lozenge. METHODS: One hundred forty-five smokers were each tested twice, once after receiving nicotine, and once after receiving placebo lozenge in counterbalanced order. Participants completed various tests of incentive motivational functioning: a measure of subjective enjoyment, the Snaith-Hamilton pleasure scale (SHAPS); a simple card sorting task, the card arranging reward responsivity objective test (CARROT) with and without financial incentive; the modified emotional Stroop test; a cue-reactivity task; and a novel reaction time task to explore effects of signals of reward, the incentive motivational enhancement of response speed task. RESULTS: Compared with performance during abstinence (placebo condition), nicotine was associated with: higher self-reported pleasure expectations on the SHAPS; enhanced responsiveness to financial reward on the CARROT in smokers who smoked 15 or more cigarettes a day; and greater interference from appetitive words on the Stroop task. CONCLUSIONS: These results are generally consistent with contemporary neurobiological theories of addiction and suggest that short-term smoking abstinence is associated with impaired reward motivation which can be reversed with nicotine.
Authors: Sean P David; Marcus R Munafò; Heidi Johansen-Berg; Stephen M Smith; Robert D Rogers; Paul M Matthews; Robert T Walton Journal: Biol Psychiatry Date: 2005-07-14 Impact factor: 13.382
Authors: Andrew J Waters; Saul Shiffman; Michael A Sayette; Jean A Paty; Chad J Gwaltney; Mark H Balabanis Journal: Health Psychol Date: 2003-07 Impact factor: 4.267
Authors: C Martin-Soelch; A F Chevalley; G Künig; J Missimer; S Magyar; A Mino; W Schultz; K L Leenders Journal: Eur J Neurosci Date: 2001-10 Impact factor: 3.386
Authors: Lauren B Alloy; Rachel E Bender; Wayne G Whitehouse; Clara A Wagner; Richard T Liu; David A Grant; Shari Jager-Hyman; Ashleigh Molz; James Y Choi; Eddie Harmon-Jones; Lyn Y Abramson Journal: J Abnorm Psychol Date: 2011-10-17
Authors: Lynne Dawkins; Jane H Powell; Robert West; John Powell; Alan Pickering Journal: Psychopharmacology (Berl) Date: 2007-01-05 Impact factor: 4.530
Authors: Ruth S Barr; Diego A Pizzagalli; Melissa A Culhane; Donald C Goff; A Eden Evins Journal: Biol Psychiatry Date: 2007-11-05 Impact factor: 13.382
Authors: John D Ragland; Roshan Cools; Michael Frank; Diego A Pizzagalli; Alison Preston; Charan Ranganath; Anthony D Wagner Journal: Schizophr Bull Date: 2008-10-16 Impact factor: 9.306